MDCT imaging in malignant carcinoid syndrome [PDF]
Indian Journal of Gastroenterology, 2011 A 65-year-old lady presented with sudden onset of palpitations, headache, perspirations and flushing. Clinical examination revealed tenderness in right lumbar region. Ultrasound abdomen revealed multiple hyperechoic hepatic lesions and a mesenteric mass.
Kamini Gupta +3 more
semanticscholar +6 more sources
Therapeutic Considerations for the Malignant Carcinoid Syndrome [PDF]
Acta Oncologica, 1989 Symptomatology and pathophysiology of carcinoid syndrome are summarized and the therapeutic possibilities reviewed. It is underlined that severity of symptoms and effect of the disease on vital organ function should be considered in order to tailor treatment appropriately.
Larry K. Kvols
semanticscholar +4 more sources
A study of cyproheptadine in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome [PDF]
Cancer, 1991 Sixteen patients with metastatic neuroendocrine tumors and the malignant carcinoid syndrome were treated with cyproheptadine (Periactin, Merck, Sharp & Dohme, West Point, PA) at maximum tolerable doses that ranged from 12 to 48 mg daily. Usual side effects were mild sedation and dry mouth, but three patients found it impossible to sustain treatment due
Charles G. Moertel +2 more
semanticscholar +5 more sources
OBSERVATIONS ON A PATIENT WITH THE MALIGNANT CARCINOID SYNDROME [PDF]
Journal of Clinical Pathology, 1959 Rosemary Cass +3 more
semanticscholar +6 more sources
Metastatic Carcinoid Tumors and the Malignant Carcinoid Syndrome [PDF]
Acta Oncologica, 1993 Patients with metastatic carcinoid tumors and the malignant carcinoid syndrome have benefited immensely from diagnostic and therapeutic advances during the past decade. Magnetic resonance imaging and whole body scintigraphy with radiolabelled analogues of somatostatin have improved our ability to diagnose, detect, stage and follow response to therapy ...
Larry K. Kvols, Jean Claude Reubi
openaire +3 more sources
Carcinoid syndrome due to a malignant somatostatinoma [PDF]
Postgraduate Medical Journal, 1995 Abstract Somatostatinoma is one of the rarest tumours of the endocrine pancreas. Cardinal manifestations of a somatostatinoma include gallstones, mild diabetes mellitus, steatorrhoea, diarrhoea and dyspepsia. Like any other pancreatic islet cell carcinoma, a somatostatinoma may also produce several different hormones such as ...
Ömer Özbakir +6 more
openaire +4 more sources
Gastroenterology, 1980 The effect of intravenous somatostatin infusion was investigated in a patient with severe secretory diarrhea due to malignant carcinoid syndrome. Continuous somatostatin infusion for 48 hr (4 microgram/kg/hr) reduced stool volume from 2.2 to 0.7 liters ...
Glenn R. Davis +3 more
semanticscholar +4 more sources
A Case of Carcinoid Syndrome Due to Malignant Metastatic Carcinoid Tumor with Carcinoid Heart Disease Involving Four Cardiac Valves [PDF]
The American journal of case reports, 2018 Patient: Female, 62 Final Diagnosis: Carcinoid heart disease Symptoms: Abdominal discomfort • diarrhea • fatigue • weight loss Medication: — Clinical Procedure: — Specialty: Cardiology Objective: Rare disease Background: Carcinoid tumor, benign, low ...
Brianna Shinn +2 more
openalex +2 more sources
Synchronous bilateral typical pulmonary carcinoid tumours diagnosed by robotic navigation bronchoscopy: A unique case [PDF]
Respirology Case ReportsPulmonary carcinoids are uncommon malignant neoplasms, believed to derive from specialized neuroendocrine cells known as Kulchitsky cells. We evaluated a 69‐year‐old female presenting symptoms consistent with carcinoid syndrome, such as intermittent ...
Menna Megahed +2 more
doaj +2 more sources
Long-term results of patients with malignant carcinoid syndrome receiving octreotide LAR [PDF]
Alimentary Pharmacology and Therapeutics, 2009 Christos Toumpanakis +7 more
openalex +2 more sources